Pöyry PLC: Financial Statement Release 2016 Pöyry

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
105
Pöyry PLC: Financial Statement Release 2016

Pöyry PLC          Financial statement release 8 February 2017 at 8.30 a.m. EET

Further operational improvement

Key figures for October-December 2016

 (Figures in brackets, unless otherwise stated, refer to the same period of the previous year.)

  • Adjusted operating result increased to EUR 4.3 (2.7) million. Operating result was EUR -2.9 (0.1) million.  
  • Net sales were EUR 130.5 (144.5) million.  
  • Order intake increased compared to the corresponding period in the previous year.

Key figures for January-December 2016

  • Adjusted operating result decreased to EUR 5.8 (9.4) million. It improved in the Management Consulting Business Group, but declined in the other business lines. Operating result was EUR -8.1 (4.0) million.  
  • Net sales were EUR 529.6 (575.3) million. They remained stable in the Management Consulting Business Group but decreased in the other business lines.  
    • The Group's order stock was EUR 442.5 (465.5) million.
        10-12/ 10-12/ Change, 1-12/ 1-12/ Change,
Pöyry Group     2016 2015 % 2016 2015 %
Order stock at the end of period, EUR million   442.5 465.5 -4.9 442.5 465.5 -4.9
Net sales total, EUR million   130.5 144.5 -9.7 529.6 575.3 -7.9
Operating result, EUR million   -2.9 0.1 n.a. -8.1 4.0 n.a.
Operating margin, %   -2.2 0.1   -1.5 0.7  
Adjusted operating result, EUR million   4.3 2.7 57.9 5.8 9.4 -38.0
Adjusted operating margin, %   3.3 1.9   1.1 1.6  
Result before taxes, EUR million   -4.0 -0.9 n.a. -10.6 6.0 n.a.
Earnings per share, basic, EUR   -0.09 0.00 n.a. -0.24 0.09 n.a.
Earnings per share, diluted, EUR   -0.09 0.00 n.a. -0.24 0.09 n.a.
Earnings per share, adjusted, EUR   0.03 0.04 -27.7 -0.01 0.18 n.a.
Gearing, %         27.0 3.6  
Return on investment, %         -3.2 6.1  
Average number of personnel, full time equivalents (FTE)         4,839 5,029 -3.8

All figures and sums have been rounded off from the exact figures, which may lead to minor discrepancies upon addition or subtraction.

Martin à Porta, President and CEO:

"Our adjusted operating result increased compared to the same quarter in 2015, showing continued improvement in our operational business. Adjusted operating margin increased in the Energy and Management Consulting Business Groups, remained on a solid level in the Industry Business Group and declined in Regional Operations. Accordingly operating cash flow of the quarter excluding taxes improved compared to the corresponding period in the previous year. We also saw an increase in our order stock as an outcome from a more client focussed organisation.

There has been strong operational improvement in the organisation. Employee engagement has increased, resulting in better motivation and energy in our teams. I am also happy that we have been able to recruit some new key employees to different levels of our organisation. Together with the good progress on our new business management system, which better equips our employees, this will lead to increased margins in our projects. There are also encouraging signs that our new offerings in the areas of bioenergy, health and safety and operational excellence are getting good response from the market. All in all our sales efforts have resulted in better prospects and opportunities in the market. We believe we can materialise a number of these in order intake in the next few months."

Board of Directors' proposal for disposal of distributable funds

The Group's parent company Pöyry PLC's net result for 2016 amounted to EUR 4,383,237.51 and retained earnings were EUR 25,840,897.23. The total distributable earnings were EUR 30,224,134.74. The Board of Directors of Pöyry PLC will propose to the Annual General Meeting on 9 March 2017 that no dividend will be paid for the year 2016.

Financial outlook for 2017

The Group's adjusted operating result is estimated to improve.

Market outlook 2017

Uneven economic developments among the major economies are expected to continue in 2017. The growth in the Eurozone has been modest. There are indications of market recovery, but high unemployment may weaken consumer demand and slow down the improving economic growth. Despite some signs of an economic recovery in Brazil, the market situation is still tight. At the same time, growth in the U.S. and in the majority of Asian countries remains positive, fuelled by stronger domestic demand.

For the businesses relevant to Pöyry, the sector specific outlook remains mixed. In the forest product industry sectors, such as packaging and tissue, the outlook is good, whereas in the graphic paper industry the demand continues to decline. The energy market is facing structural changes in Europe.

Events after the reporting period

As part of its improved client focus, Pöyry concentrates its globally-focused competences and process know-how in Pulp, Paper & Board, Chemicals & Biorefining and Mining & Metals in one global Industry organisation. This enables us to develop smart solutions and new innovations in connected teams, addressing global megatrends such as bioeconomy, efficiency and digitalisation.

Pöyry is reinforcing its project implementation approach and global delivery model in project management, health and safety, engineering and construction management by bringing together its industry-related operations in Brazil, Finland and Germany from Regional Operations to the Industry Business Group.

Pöyry's financial reporting will continue to be based on the following four reporting segments: Management Consulting Business Group; Industry Business Group; Energy Business Group; and Regional Operations. Restated figures will be published before the 4 August 2017 publication of the half year financial report January - June 2017.

Corporate governance statement

Pöyry will publish its Corporate Governance Statement 2016 and its Annual Review 2016, including the financial statements and the Report of the Board of Directors, on 16 February 2017 at the latest. The Corporate Governance Statement will be published separately from the Annual Review, and will be published on the company's website at www.poyry.com .

Materials to the AGM

The Annual Review 2016 including the financial statements and the Board of Directors' report as well as other documents presented to the Annual General Meeting will be published on the company's website at www.poyry.com on 16 February 2017 at the latest.

This is a summary of the January-December 2016 financial statement release. The complete financial statement release is enclosed with this stock exchange release and is available in full on the company's website at www.poyry.com . Investors are advised to review the complete financial statement release with tables.

PÖYRY PLC

Additional information: Juuso Pajunen, CFO Tel. +358 10 33 26632

Invitation to conference call today on 8 February 2017

The result will be presented in English at a conference for analysts, investors and the press at 1:00 p.m. Finnish time (EET). The conference will be held at Pöyry house, Jaakonkatu 3, Vantaa, Finland. The event will be hosted by Martin à Porta, President and CEO, and Juuso Pajunen, CFO. The participants who will attend the conference at Pöyry house have been requested to inform about their participation by 3 February 2017. 

The participants can also join a conference call that will be arranged in conjunction with the conference. The conference call details can be found below.

A live webcast of the conference can be followed online on the company's website at www.poyry.com/investors . A recording will be made available by the next working day on the same website.

To attend the conference call, please dial:

FI:                         +358 (0)9 7479 0361 SE:                       +46 (0)8 5033 6574 UK:                      +44 (0)330 336 9105 US:                      +1 719 457 1036 Other countries: +44 (0)330 336 9105

Conference ID: 4421323

Due to the nature of the live webcast, we kindly ask those attending the conference call to dial in 5-10 minutes prior to the start of the event.

Pöyry is an international consulting and engineering company.  We deliver smart solutions across power generation, transmission & distribution, forest industry, chemicals & biorefining, mining & metals, transportation and water. Pöyry's net sales in 2016 were EUR 530 million. The company's shares are quoted on Nasdaq Helsinki (POY1V). Approximately 5,500 experts. 40 countries. 130 offices.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...510a073465

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading